Find clinical trials for Multiple Myeloma in Indianapolis, IN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Indianapolis, IN, USA:
This is a Phase I dose-finding study of FT576 as monotherapy and in combination with the monoclonal antibody daratumumab in multiple myeloma...
Phase 1
Indianapolis, Indiana, United States and 13 other locations
A Phase 2, open-label, dose escalation study to evaluate the safety and efficacy of venetoclax in combination with carfilzomib-dexamethasone (Kd) in...
Phase 2
Indianapolis, Indiana, United States and 31 other locations
versus standard regimens in subjects with relapsed and refractory multiple myeloma (RRMM).The study is anticipated to randomize app...
Phase 3
Indianapolis, Indiana, United States and 59 other locations
This is a post-trial access (PTA) open-label, single-arm study in Multiple Myeloma participants who continue to derive clinical ben...
Phase 4
Indianapolis, Indiana, United States and 12 other locations
provide clinical benefit in participants with relapsed/refractory multiple myeloma. Elranatamab is a bispecific antibody: binding o ...
Phase 2
Indianapolis, Indiana, United States and 78 other locations
This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called multiple...
Phase 1
Indianapolis, Indiana, United States and 38 other locations
B-cell maturation antigen (BCMA) is a target present on tumor cells in participants with multiple myeloma. Belantamab mafodotin (GS...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 58 other locations
The purpose of this study is to learn about the study medicine called elranatamab.This study aims to compare elranatamab to other medicines for the t...
Phase 3
Indianapolis, Indiana, United States and 117 other locations
The purpose of this study is to characterize the safety and tolerability of teclistamab when administered in different combination regimen and to ide...
Phase 1
Indianapolis, Indiana, United States and 26 other locations
The purpose of this study is to characterize the safety and tolerability of talquetamab when administered in different combination regimens and to id...
Phase 1
Indianapolis, Indiana, United States and 30 other locations
Clinical trials
Research sites
Resources
Legal